Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Recent Advances in the Fabrication of Nano-Aptasensors for the Detection of Troponin As a Main Biomarker of Acute Myocardial Infarction Publisher Pubmed



Kazemi Asl S1 ; Rahimzadegan M2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Strategic Reading of Education and Development Center of Medical Sciences, Ministry of Health& Medical Education of I.R, Tehran, Iran
  2. 2. Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pharmacology and Toxicology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Critical Reviews in Analytical Chemistry Published:2023


Abstract

Acute myocardial infarction (AMI) as the one of the main health threatening refers to reduced blood flow to the myocardium resulting in higher proportion of morbidity and mortality. Currently, cardiac troponin I (cTnI) and cardiac troponin T (cTnT) which have been regarded as the main specific AMI-related biomarkers which was predominant in AMI. Recently, aptamer-based biosensors or aptasensors have attracted special attention to accessible and sensitive detection of cardiac troponin. Moreover, the nanomaterials (NMs)/aptamer conjugates have opened new prospects in high accuracy detection of cTnI and cTnT as nanoaptasensors. This review gathered a clear and concise statements of the recent advancement of the various types of optical and electrochemical-based aptasensors and nanoaptasensors that have been developed for determination of troponin. Subsequently, future perspectives and challenges of aptamer-based cTnI and cTnT detection are discussed briefly. © 2021 Taylor & Francis Group, LLC.